
                         Roanoke Times
                 Copyright (c) 1995, Landmark Communications, Inc.

DATE: THURSDAY, November 18, 1993                   TAG: 9311180130
SECTION: NATIONAL/INTERNATIONAL                    PAGE: A-18   EDITION: METRO 
SOURCE: 
DATELINE: LONG BEACH, CALIF.                                LENGTH: Short

FDA APPROVES RU-486 IN BREAST CANCER TEST

The U.S. Food and Drug Administration has approved clinical tests of the French abortion pill RU-486 to treat women with advanced breast cancer.

The Breast Center and Cancer Institute at Long Beach Memorial Medical Center is seeking 40 women for the trial whose cancer has spread beyond the breast.

The subjects must have responded in the past to some form of hormonal cancer treatment such as removal of the ovaries or use of the drug tamoxifen, center Director Dr. John Link said Wednesday.

RU-486 is used in Europe for ending pregnancies but hasn't been approved for that purpose in the United States. - Associated Press

by CNB